Menachem Laufer

Tel Aviv University

Papers

1

Total Citations

8

H-Index

1

About

Menachem Laufer is a leading figure in urologic oncology, with a focused expertise in minimally invasive surgical techniques for renal cell carcinoma. His primary research investigates the comparative safety and efficacy of robotic-assisted, laparoscopic, and open partial nephrectomy. Laufer’s most cited work, a 2024 study, made a pivotal contribution by demonstrating that robotic-assisted partial nephrectomy (RAPN) is associated with a significantly lower incidence of postoperative renal artery pseudoaneurysm (RAP)—a rare but life-threatening complication—compared to both laparoscopic and open approaches. This finding has direct implications for surgical decision-making, suggesting that the precision of robotic technology may reduce vascular injury risk. With 8 citations in a short period, this paper is already shaping clinical guidelines. Laufer’s broader research portfolio continues to advance the safety profile of nephron-sparing surgery, helping to establish robotic techniques as the gold standard for complex renal tumors. His work is essential reading for surgeons and trainees seeking to optimize patient outcomes in urologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Robotic partial nephrectomy is associated with a significantly decreased rate of postoperative pseudoaneurysm compared to open and laparoscopic partial nephrectomy
8 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Tel Aviv University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago